Medtronic has received CE Mark for the Evera portfolio of implantable cardioverter-defibrillators (ICDs).
With increased longevity and SmartShock shock reduction technology, Minneapolis-based Medtronic said the new family of ICDs is the first to feature the PhysioCurve design, a contoured shape. In addition, Evera also is paired with the Sprint Quattro Secure lead. Also included in the new ICD portfolio is OptiVol 2.0 fluid status monitoring and complete diagnostics.
The Medtronic Evera ICD is not approved in the U.S.